eli lilly's tirzepatide is the leader in weight loss sector Why Lilly Stock Jumped to a Record High on Tuesday Eli Lilly's weight loss, diabetes

In March 2025, the FDA approved Sanofi/Alnylam Pharmaceuticals Qfitlia (fitusiran), an RNAi therapeutic to prevent or reduce the frequency of bleeding episodes in adult and paediatric patients (aged 12 years of age and over) with haemophilia A or B, with or without factor VIII or IX inhibitors

A healthy gut microbiome, in turn, supports better nutrient absorption and overall digestive health

Naranjo score: 6 (probable)

Collected data included demographics, clinical measures, laboratory results, and treatment details

GOLO offers a growing selection of dietary supplements without peer-reviewed third-party studies to vouch for their safety and effectiveness

If you use them correctly, they can work together to give you clearer, brighter, and more even skin